retatrutide expanded access compassionate use eli lilly STAT reports and the FDA granted a single 79-year-old man compassionate-use to retatrutide, an experimental obesity drug millions are waiting on. The request reportedly drew interest from senior health Eli Lilly Chose One 79-Year-Old

Escalating the dose of a single compound eventually hits diminishing returns or triggers dose-dependent side effects without proportional metabolic benefit

What happens if I accidentally shake the vial after mixing

Why Nutrition Still Matters Even When Appetite Is Reduced GLP-1 medications help with weight loss largely by reducing appetite, increasing fullness, and lowering food intake

An analysis of deformities in revision surgeries for secondary unilateral cleft lip

The older you are, the greater the risk of developing a form of dementia

Many plans in California now include free or discounted preventive care, and there may be added support for many patients who take medications known to affect oral health